39916 Investors following Ranbaxy Labs. Share this News with them.
0
Like this story, share it with millions of investors on M3
Ranbaxy Dec PAT seen at Rs 396.2cr: P Lilladher
Prabhudas Lilladher has come out with its earning estimates for pharmaceutical sector for the quarter ended December 2009. According to the research firm, Ranbaxy Laboratories December quarter net sales are expected to go down by 12.6% to Rs 1746.6 crore on YoY basis.
Prabhudas Lilladher has come out with its earning estimates for pharmaceutical sector for the quarter ended December 2009. According to the research firm, Ranbaxy Laboratories December quarter net sales are expected to go down by 12.6% to Rs 1746.6 crore on YoY basis.
The company's net profit is expected to go down by 158.3% to Rs 396.2 crore on YoY basis.
